Literature DB >> 22396841

Massive intracerebral hemorrhage caused by a cavernous malformation.

Young Soo Kim1, Jae Il Lee, Chang Hwa Choi, Jun Kyeung Ko.   

Abstract

We present a rare case of massive intracerebral hemorrhage resulting from a small, superficially-located supratentorial cavernous malformation, or cavernoma. These lesions rarely lead to massive, life-threatening intracerebral hemorrhages. A 17-year-old female presented with a 3-week history of declining mental status. Brain computed tomography and magnetic resonance imaging revealed a sizable intracranial hemorrhage, within the right occipital region, associated with a small nodule at the hematoma's posterior margin. An emergency operation removed the entire hematoma and nodule. Histological examination of the nodule was compatible with a diagnosis of cavernous malformation. The patient's post-operative course was uneventful.

Entities:  

Keywords:  Cavernous malformation; Intracerebral hemorrhage

Year:  2012        PMID: 22396841      PMCID: PMC3291704          DOI: 10.3340/jkns.2012.51.1.37

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


INTRODUCTION

Cavernous malformations are benign vascular lesions of the central nervous system characterized by a mulberry-like cluster of thin-walled vascular sinusoids lined by a thin endothelium, which lacks smooth muscle, elastin, or intervening brain tissue5,16). Cavernous malformations have an annual bleeding incidence of 0.2-2.3%9,10). Most hemorrhages attributable to cavernous malformations are characterized by microhemorrhages and are seldom catastrophic or fatal. Most notably, supratentorial cavernous malformations leading to massive, life-threatening hemorrhages are rare entities4,7). In this report, we describe a case with a supratentorial cavernous malformation resulting in a life-threatening, massive hemorrhage.

CASE REPORT

A 17-year-old female who had no significant prior medical history was brought to the emergency department because of a fall three weeks prior to admission and an increasing state of confusion ever since. Her mental status had reportedly been declining for three weeks. The patient was afebrile, and her physical examination results were unremarkable at the time of admission. A neurological examination revealed a decreased level of consciousness, namely severe confusion, with orientation and cooperation disorders. However, the patient could localize painful stimuli. Her Glasgow Coma Scale score was 10 (E2, M5, V3). Cranial computerized tomography (CT) revealed a well-circumscribed, 5.5 cm-diameter mass in the right occipital region, causing a midline shift and right lateral ventricle compression (Fig. 1A). The lesion seemed to be composed of a small, hyperdense, acutely hemorrhagic nodule and a large, peripheral, isodense early subacute hematoma. Magnetic resonance imaging (MRI) confirmed that the lesion comprised an acutely hemorrhagic nodule, isointense with deoxyhemoglobin, and a larger subacute hematoma, which was hyperintense due to the presence of methemoglobin (inferred because it was hyperintense on T1-weighted but hypointense on T2-weighted images; Fig. 1B, C). A T2-weighted MRI revealed the classic "popcorn ball" configuration of cavernous malformations at the hematoma's posterior margin (Fig. 1D). Using a right parieto-occipital craniotomy, we evacuated the multi-staged intracerebral hematoma excising a well-circumscribed, purple, lobulated mass consisting of vascular structures in its entirety. Our pathological findings were consistent with a cerebral cavernous malformation (Fig. 2). The patient's post-operative period was uneventful. Her consciousness level was gradually improved, and she was discharged on the ninth post-operative day. A final CT scan at the end of her hospitalization revealed no residual mass (Fig. 3). She returned to her previous occupation as a student, with no neurological deficits, three weeks later.
Fig. 1

Pre-treatment computerized tomography and magnetic resonance images. Axial computerized tomography (A) shows a large, hemorrhagic lesion, with a hyperdense acutely hemorrhagic nodule, within the right occipital lobe, causing a midline shift and right lateral ventricle compression. Axial (B) and coronal (C) T1-weighted magnetic resonance images after gadolinium injection demonstrate that the lesion comprises an acutely hemorrhagic nodule (arrows), isointense with deoxyhemoglobin, and a larger subacute hematoma (asterisks), which is hyperintense due to methemoglobin. An axial T2-weighted image (D) reveals the classic "popcorn ball" configuration of a cavernous malformation (arrow) at the hematoma's posterior margin.

Fig. 2

Low power photomicrograph shows a lesion consisting of randomly distributed telangiectatic and congested vascular channels in a stroma, with little intervening neural tissue. The vessels are separated by fibrotic tissue containing hemosiderin deposition (H&E stain, ×100).

Fig. 3

Follow-up computerized tomography performed nine days after surgery, showing no space-occupying lesion and no pathological densities.

DISCUSSION

Cavernous malformations have a wide range of presenting symptoms, varying from mild, such as headaches, to more severe symptoms, including seizures, focal neurological deficits, and even death. Epilepsy is the most common clinical manifestation in supratentorial lesions and is seen in 40-50% of such cases1,2,9-11,15). Researchers have ascribed cavernous malformations' epileptogenicity to the deposition of iron and other blood breakdown products6,8). All of the above symptoms can occur with or without acute hemorrhage. Since the definition of "hemorrhage" varies greatly from study to study, the percentage of patients presenting with hemorrhage shows a wide range, from a low of 9% to a high of 88%1,2,15). Reportedly, cavernous malformations have an annual bleeding incidence ranging from 0.2% to 2.3%. Del Curling et al.9) reported symptomatic hemorrhage rates of 0.25% per patient-year and 0.10% per lesion-year. Kim et al.10) reported symptomatic hemorrhage rates of 2.3% per patient-year and 1.4% per lesion-year. Recently, Washington et al.15) reported on the factors that increase the cavernous malformation hemorrhagic risk. Patients with a previous history of bleeding are at higher risk for a new hemorrhage than are those presenting with incidental findings or with a seizure2,12). In addition, female sex and a family history of hemorrhage increase the risk of bleeding2,14). Furthermore, anatomic location affects the risk. Porter et al.14) reported a higher rate of recurrent symptomatic hemorrhage in infratentorial than in supratentorial lesions (3.8% per patient-year vs. 0.4% per patient-year) and a higher rate in deep than in superficial lesions (4.1% per patient-year vs. 0% per patient-year). Brain stem lesions, in particular, have an aggressive clinical course11). The indications for, and timing of, cavernous malformations surgery are still unclear. The risk of a significant hemorrhage due to the malformation is relatively low, so hemorrhage prevention should not be an absolute surgical indication. However, clinicians are in general agreement on the need for resection surgery in symptomatic cavernous malformations, particularly for those in superficial, non-eloquent areas. The present case suggests emergency surgery may be necessary in patients with unstable clinical conditions and/or with lesions causing a significant mass effect. Radiosurgery remains controversial, and clinicians require more data to evaluate its efficacy. Although almost all cavernous malformation cases experience microhemorrhages, such bleeding rarely leads to clinical symptoms. Since these lesions have small diameters and low flow rates, they rarely cause life-threatening intracerebral hematomas13). Zimmerman et al.17) reported one patient who died from rehemorrhage of a tectal cavernous malformation. There are consequences, however, even of repeated small hemorrhages. In our case, we can also suspect rehemorrhage on the basis of various radiologic findings. Nevertheless, our case lacked a previous history of headaches, epilepsy, or neurological deficits but presented with a massive intracerebral hemorrhage from a small, superficially-located supratentorial cavernous malformation. To our knowledge, only one case of massive intracerebral hemorrhage from a supratentorial cavernous malformation has been reported previously3). Unlike our case, it resulted from a giant cavernous malformation, 42×35 mm. Thus, ours is the first report of a massive intracerebral hematoma resulting from a small, superficially-located, supratentorial cavernous malformation.

CONCLUSION

We presented the case of a massive intracerebral hematoma caused by a small, superficially-located supratentorial cavernous malformation with clinical features and a review of the literature.
  17 in total

1.  Supratentorial cerebral cavernous malformations: clinical, surgical, and genetic involvement.

Authors:  Vincenzo Antonio D'Angelo; Costanzo De Bonis; Rosina Amoroso; Alessandro Cali; Leonardo D'Agruma; Vito Guarnieri; Lucia Anna Muscarella; Leopoldo Zelante; Michele Bisceglia; Tommaso Scarabino; Domenico Catapano
Journal:  Neurosurg Focus       Date:  2006-07-15       Impact factor: 4.047

2.  Natural history of brainstem cavernous malformations.

Authors:  M J Kupersmith; H Kalish; F Epstein; G Yu; A Berenstein; H Woo; J Jafar; G Mandel; F De Lara
Journal:  Neurosurgery       Date:  2001-01       Impact factor: 4.654

3.  An analysis of the natural history of cavernous malformations.

Authors:  D S Kim; Y G Park; J U Choi; S S Chung; K C Lee
Journal:  Surg Neurol       Date:  1997-07

Review 4.  Pathology of cerebral vascular malformations.

Authors:  J M Zabramski; J S Henn; S Coons
Journal:  Neurosurg Clin N Am       Date:  1999-07       Impact factor: 2.509

Review 5.  Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation.

Authors:  Chad W Washington; Kathleen E McCoy; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

6.  Treatment and outcome of children with cerebral cavernomas: a survey on 32 patients.

Authors:  Alessandro Consales; Gianluca Piatelli; Marcello Ravegnani; Marco Pavanello; Pasquale Striano; Maria Luisa Zoli; Valeria Capra; Andrea Rossi; Maria Luisa Garrè; Maria Grazia Calevo; Armando Cama
Journal:  Neurol Sci       Date:  2009-10-16       Impact factor: 3.307

7.  Giant cavernous malformation of the occipital lobe.

Authors:  Carlos Filipe Chicani; Neil R Miller; Rafael J Tamargo
Journal:  J Neuroophthalmol       Date:  2003-06       Impact factor: 3.042

8.  Huge cavernoma with massive intracerebral hemorrhage in a child.

Authors:  Emel Avci; Adi Oztürk; Füsun Baba; Hamza Karabağ; Ahmet Cakir
Journal:  Turk Neurosurg       Date:  2007       Impact factor: 1.003

9.  Long-term outcome of patients with multiple cerebral cavernous malformations.

Authors:  Juri Kivelev; Mika Niemelä; Riku Kivisaari; Reza Dashti; Aki Laakso; Juha Hernesniemi
Journal:  Neurosurgery       Date:  2009-09       Impact factor: 4.654

10.  Cavernous malformations of the central nervous system in the pediatric age group.

Authors:  Nicola Acciarri; Ercole Galassi; Marco Giulioni; Eugenio Pozzati; Vincenzo Grasso; Giorgio Palandri; Filippo Badaloni; Mino Zucchelli; Fabio Calbucci
Journal:  Pediatr Neurosurg       Date:  2009-03-21       Impact factor: 1.162

View more
  3 in total

1.  [Cavernomas of the central nervous system : Observational study of 111 patients].

Authors:  C Mayer; U M Mauer; G Bluhm; R Mathieu; C Hackenbroch; S Mayer
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

2.  Chronic encapsulated intracerebral hematoma associated with cavernous malformation.

Authors:  Satoru Takeuchi; Kojiro Wada; Fumihiro Sakakibara; Kentaro Mori
Journal:  J Korean Neurosurg Soc       Date:  2014-02-28

3.  Two cases of cavernous malformation presenting with unusual and large intracerebral hemorrhages.

Authors:  Yeon-Ju Choi; Ki-Su Park; Seong-Hyun Park; Jeong-Hyun Hwang
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2015-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.